298 related articles for article (PubMed ID: 25099489)
1. Hydrogen sulfide treatment reduces blood pressure and oxidative stress in angiotensin II-induced hypertensive mice.
Al-Magableh MR; Kemp-Harper BK; Hart JL
Hypertens Res; 2015 Jan; 38(1):13-20. PubMed ID: 25099489
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen sulfide improves endothelial dysfunction in hypertension by activating peroxisome proliferator-activated receptor delta/endothelial nitric oxide synthase signaling.
Xiao L; Dong JH; Teng X; Jin S; Xue HM; Liu SY; Guo Q; Shen W; Ni XC; Wu YM
J Hypertens; 2018 Mar; 36(3):651-665. PubMed ID: 29084084
[TBL] [Abstract][Full Text] [Related]
3. Decreased vascular H2S production is associated with vascular oxidative stress in rats fed a high-fat western diet.
Jenkins TA; Nguyen JC; Hart JL
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):783-90. PubMed ID: 27087304
[TBL] [Abstract][Full Text] [Related]
4. Hydrogen sulfide ameliorated L-NAME-induced hypertensive heart disease by the Akt/eNOS/NO pathway.
Jin S; Teng X; Xiao L; Xue H; Guo Q; Duan X; Chen Y; Wu Y
Exp Biol Med (Maywood); 2017 Dec; 242(18):1831-1841. PubMed ID: 28971696
[TBL] [Abstract][Full Text] [Related]
5. Hydrogen Sulfide Improves Myocardial Remodeling via Downregulated Angiotensin Ⅱ/AT1R Pathway in Renovascular Hypertensive Rats.
Liu SY; Duan XC; Jin S; Teng X; Xiao L; Xue HM; Wu YM
Am J Hypertens; 2017 Jan; 30(1):67-74. PubMed ID: 27600580
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen sulfide ameliorates hypertension and vascular dysfunction induced by insulin resistance in rats by reducing oxidative stress and activating eNOS.
Silva-Velasco DL; Hong E; Beltran-Ornelas JH; Sánchez-López A; Huerta de la Cruz S; Tapia-Martínez JA; Gomez CB; Centurión D
Eur J Pharmacol; 2024 Jan; 963():176266. PubMed ID: 38096969
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen sulfide protects endothelial nitric oxide function under conditions of acute oxidative stress in vitro.
Al-Magableh MR; Kemp-Harper BK; Ng HH; Miller AA; Hart JL
Naunyn Schmiedebergs Arch Pharmacol; 2014 Jan; 387(1):67-74. PubMed ID: 24068103
[TBL] [Abstract][Full Text] [Related]
8. Involvement of hydrogen sulfide and homocysteine transsulfuration pathway in the progression of kidney fibrosis after ureteral obstruction.
Jung KJ; Jang HS; Kim JI; Han SJ; Park JW; Park KM
Biochim Biophys Acta; 2013 Dec; 1832(12):1989-97. PubMed ID: 23846016
[TBL] [Abstract][Full Text] [Related]
9. Chronic NaHS treatment decreases oxidative stress and improves endothelial function in diabetic mice.
Ng HH; Yildiz GS; Ku JM; Miller AA; Woodman OL; Hart JL
Diab Vasc Dis Res; 2017 May; 14(3):246-253. PubMed ID: 28467198
[TBL] [Abstract][Full Text] [Related]
10. The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase.
Zhong G; Chen F; Cheng Y; Tang C; Du J
J Hypertens; 2003 Oct; 21(10):1879-85. PubMed ID: 14508194
[TBL] [Abstract][Full Text] [Related]
11. [Exogenous hydrogen sulfide reduces vascular aging in D-galactose-induced subacute aging rats].
Qiao WL; Yang WX; Liu L; Shi Y; Cui J; Liu H; Yan CD
Sheng Li Xue Bao; 2014 Jun; 66(3):276-82. PubMed ID: 24964843
[TBL] [Abstract][Full Text] [Related]
12. DL-propargylglycine reduces blood pressure and renal injury but increases kidney weight in angiotensin-II infused rats.
Oosterhuis NR; Frenay AR; Wesseling S; Snijder PM; Slaats GG; Yazdani S; Fernandez BO; Feelisch M; Giles RH; Verhaar MC; Joles JA; van Goor H
Nitric Oxide; 2015 Sep; 49():56-66. PubMed ID: 26192363
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase 6 inhibitor tubastatin A attenuates angiotensin II-induced hypertension by preventing cystathionine γ-lyase protein degradation.
Chi Z; Byeon HE; Seo E; Nguyen QT; Lee W; Jeong Y; Choi J; Pandey D; Berkowitz DE; Kim JH; Lee SY
Pharmacol Res; 2019 Aug; 146():104281. PubMed ID: 31125601
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen sulfide suppresses angiotensin II-stimulated endothelin-1 generation and subsequent cytotoxicity-induced endoplasmic reticulum stress in endothelial cells via NF-κB.
Hu HJ; Jiang ZS; Zhou SH; Liu QM
Mol Med Rep; 2016 Nov; 14(5):4729-4740. PubMed ID: 27748925
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II downregulates vascular endothelial cell hydrogen sulfide production by enhancing cystathionine γ-lyase degradation through ROS-activated ubiquitination pathway.
Bai L; Qi Y; Chen S; Wang J; Tang C; Du J; Jin H; Huang Y
Biochem Biophys Res Commun; 2019 Jun; 514(3):907-912. PubMed ID: 31084929
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II infusion alters vascular function in mouse resistance vessels: roles of O and endothelium.
Wang D; Chabrashvili T; Borrego L; Aslam S; Umans JG
J Vasc Res; 2006; 43(1):109-19. PubMed ID: 16340215
[TBL] [Abstract][Full Text] [Related]
17. Endogenous and exogenous hydrogen sulfide facilitates T-type calcium channel currents in Cav3.2-expressing HEK293 cells.
Sekiguchi F; Miyamoto Y; Kanaoka D; Ide H; Yoshida S; Ohkubo T; Kawabata A
Biochem Biophys Res Commun; 2014 Feb; 445(1):225-9. PubMed ID: 24508802
[TBL] [Abstract][Full Text] [Related]
18. Chronic NaHS Treatment Is Vasoprotective in High-Fat-Fed ApoE(-/-) Mice.
Ford A; Al-Magableh M; Gaspari TA; Hart JL
Int J Vasc Med; 2013; 2013():915983. PubMed ID: 23864951
[TBL] [Abstract][Full Text] [Related]
19. Targeting hydrogen sulfide as a promising therapeutic strategy for atherosclerosis.
Xu S; Liu Z; Liu P
Int J Cardiol; 2014 Mar; 172(2):313-7. PubMed ID: 24491853
[TBL] [Abstract][Full Text] [Related]
20. Decreased endogenous production of hydrogen sulfide accelerates atherosclerosis.
Mani S; Li H; Untereiner A; Wu L; Yang G; Austin RC; Dickhout JG; Lhoták Š; Meng QH; Wang R
Circulation; 2013 Jun; 127(25):2523-34. PubMed ID: 23704252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
